[HTML] sciencedirect.com

[HTML][HTML] De-escalation of antiplatelet therapy in patients with coronary artery disease: time to change our strategy?

P Sabouret, L Spadafora, D Fischman, W Ullah… - European Journal of …, 2023 - Elsevier
Dual antiplatelet therapy (DAPT) is the gold standard after acute coronary syndromes (ACS)
or chronic coronary syndromes (CCS) undergoing percutaneous coronary intervention …
被引用次数：15 相关文章
[HTML] ejinme.com

[HTML][HTML] De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?

P Sabouret, L Spadafora, D Fischman… - European Journal of …, 2023 - ejinme.com
Dual antiplatelet therapy (DAPT) is the gold standard after acute coronary syndromes (ACS)
or chronic coronary syndromes (CCS) undergoing percutaneous coronary intervention …
[PDF] researchgate.net

[PDF][PDF] De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?

P Sabouret, L Spadafora, D Fischman, W Ullah… - researchgate.net
Dual antiplatelet therapy (DAPT) is the gold standard after acute coronary syndromes (ACS)
or chronic coronary syndromes (CCS) undergoing percutaneous coronary intervention …

De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?

P Sabouret, L Spadafora, D Fischman… - European Journal of …, 2022 - europepmc.org
Dual antiplatelet therapy (DAPT) is the gold standard after acute coronary syndromes (ACS)
or chronic coronary syndromes (CCS) undergoing percutaneous coronary intervention …
[PDF] archive.org

[PDF][PDF] De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?

P Sabouret, L Spadafora, D Fischman, W Ullah… - scholar.archive.org
Dual antiplatelet therapy (DAPT) is the gold standard after acute coronary syndromes (ACS)
or chronic coronary syndromes (CCS) undergoing percutaneous coronary intervention …

De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?

P Sabouret, L Spadafora, D Fischman… - … Journal of Internal …, 2023 - publicum.umed.lodz.pl
Dual antiplatelet therapy (DAPT) is the gold standard after acute coronary syndromes (ACS)
or chronic coronary syndromes (CCS) undergoing percutaneous coronary intervention …

De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?

P Sabouret, L Spadafora, D Fischman, W Ullah… - EUROPEAN JOURNAL …, 2022 - iris.unicz.it
: Dual antiplatelet therapy (DAPT) is the gold standard after acute coronary syndromes
(ACS) or chronic coronary syndromes (CCS) undergoing percutaneous coronary …

De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?

P Sabouret, L Spadafora… - … journal of internal …, 2023 - pubmed.ncbi.nlm.nih.gov
Dual antiplatelet therapy (DAPT) is the gold standard after acute coronary syndromes (ACS)
or chronic coronary syndromes (CCS) undergoing percutaneous coronary intervention …

De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?

P Sabouret, L Spadafora, D Fischman… - … Journal of Internal …, 2023 - publicum.umed.lodz.pl
Dual antiplatelet therapy (DAPT) is the gold standard after acute coronary syndromes (ACS)
or chronic coronary syndromes (CCS) undergoing percutaneous coronary intervention …